Kangstem Biotech Co. Ltd. (217730)

Overview

Kangstem Biotech Co., Ltd. is a pioneering biopharmaceutical company based in Seoul, South Korea, established in 2010. The company is dedicated to the development of stem cell therapeutic products aimed at providing treatments for rare and incurable diseases. Leveraging advanced biotechnology, Kangstem Biotech focuses on harnessing the potential of stem cells to address various medical conditions that currently lack effective treatments. Their commitment to innovation and quality has positioned them as leaders in the regenerative medicine industry.

Products and Services

Furestem-AD: This product is developed for the treatment of subacute and chronic atopic dermatitis, a condition that causes inflammation and irritation of the skin. Furestem-AD utilizes stem cell therapy to potentially repair and regenerate damaged skin tissue, offering hope to patients suffering from this challenging dermatological condition.

Furestem-RA: Aimed at treating rheumatoid arthritis, Furestem-RA employs stem cell therapy to target and alleviate the symptoms of this autoimmune disorder. By potentially restoring joint function and reducing inflammation, this product seeks to improve the quality of life for patients dealing with rheumatoid arthritis.

Furestem-CD: This stem cell therapy product is designed for the treatment of active Crohn's disease, a chronic inflammatory bowel disease. Furestem-CD offers a novel approach to managing the symptoms and complications associated with Crohn's disease, targeting inflammation and promoting mucosal healing.

Stem Cell Conditioned Media: Kangstem Biotech also provides products such as umbilical cord blood-derived stem cell conditioned media. This media is rich in various growth factors, such as epidermal, vascular endothelium, keratinocyte, hepatocyte, transforming, and platelet-derived growth factors, along with growth and differentiation factor 11, and Fibroblast growth factor 2. These components are crucial for skin growth and regeneration, offering solutions for skin care and repair.

Stem Cell Culture Media: The KSB-3 kit, another innovative product offered by the company, is a specialized medium designed for culturing human mesenchymal stem cells. This culture media facilitates the growth and maintenance of stem cells, enabling their use in various therapeutic applications.

Cell Freezing and Thawing Platform: To support the preservation and utilization of stem cells, Kangstem Biotech provides a cell freezing and thawing platform. This technology ensures that stem cells retain their viability and functionality after being thawed, essential for their therapeutic application.

Pharmaceutical Contract Manufacturing and Development Services: Beyond their own product line, Kangstem Biotech offers contract manufacturing and development services. This allows other pharmaceutical and biotechnological companies to benefit from Kangstem Biotech’s expertise and state-of-the-art facilities for the production and development of their products.